A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells-Reference-Cited by-同舟云学术

A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells

Published:2013-06 Issue:5 Volume:67 Page:407-415
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Patra Nabanita,De Umasankar,Kim Tae Hyung,Lee Young Ju,Ahn Mee Young,Kim Nam Deuk,Yoon Jung Hyun,Choi Wahn Soo,Moon Hyung Ryong,Lee Byung Mu,Kim Hyung Sik

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference47 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Endocrine disruptors and prostate cancer risk;Prins;Endocr Relat Cancer,2008

3. Management of cancer of the prostate;Catalona;N Engl J Med,1994

4. Systemic treatment for prostate cancer;Dowling;Cancer Treat Rev,1998

5. Apicidin decreases phospholipase C gamma-1 transcript and protein in Hut-78 T lymphoma cells;Debicki;Biomed Pharmacother,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells;Cancers;2024-07-30

2. Epigenetic regulation of androgen dependent and independent prostate cancer;Advances in Cancer Research;2024

3. Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer;Cancer Cell;2023-08

4. Hybrid Histone Deacetylase Inhibitor: An Effective Strategy for Cancer Therapy;Current Medicinal Chemistry;2023-06

5. Down-regulating Effect of a Standardized Extract of CulturedLentinula edodes myceliaon Cortactin in Prostate Cancer Cells Is Dependent on Malignant Potential;Anticancer Research;2023-02-28